Loading...
319 Asia Disease Specific Drugs Reports
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Merck, Bayer, Amgen, AstraZeneca, Johnson & Johnson
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Abbvie, Pfizer, Teva Pharmaceutical Industries, Sun Pharmaceuticals Industries, Novartis
Country Covered: New Zealand
Study Period: 2019 - 2030
Major Players: Astellas Pharma, AstraZeneca, Sanofi, Eli Lilly and Company, Janssen
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, Thailand, Vietnam
Major Players: AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Eli Lilly and Company, Sanofi
Country Covered: Japan
Study Period: 2019 - 2030
Major Players: Takeda Pharmaceuticals, AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Sanofi
Country Covered: Indonesia
Study Period: 2019 - 2030
Major Players: Eli Lilly and Company, Boehringer Ingelheim, Sanofi, Novo Nordisk, AstraZeneca
Country Covered: Oman
Study Period: 2019 - 2030
Major Players: AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Sanofi, Eli Lilly and Company
Country Covered: South Korea
Study Period: 2021 - 2030
Major Players: AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Novo Nordisk, Sanofi
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Stryker, Zimmer Biomet, Conmed, Arthrex, Medtronic
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Sanofi, Novo Nordisk, Takeda Pharmaceuticals, Astellas Pharma, AstraZeneca
Country Covered: Japan
Study Period: 2019 - 2030
Major Players: Sanofi, Eli Lilly and Company, Pfizer, AstraZeneca, Johnson And Johnson
Country Covered: China
Study Period: 2019 - 2030
Major Players: Eli Lilly and Company, Boehringer Ingelheim, AstraZeneca, Sanofi, Novo Nordisk
Country Covered: Thailand
Study Period: 2019 - 2030
Major Players: Eli Lilly and Company, Boehringer Ingelheim, AstraZeneca, Sanofi, Novo Nordisk
Country Covered: Philippines
Study Period: 2019 - 2030
Major Players: Eli Lilly and Company, Boehringer Ingelheim, AstraZeneca, Sanofi, Novo Nordisk
Country Covered: Malaysia
Study Period: 2019 - 2030
Major Players: Eli Lilly and Company, Boehringer Ingelheim, AstraZeneca, Sanofi, Novo Nordisk
Country Covered: Vietnam
Study Period: 2019 - 2030
Major Players: Eli Lilly and Company, Boehringer Ingelheim, AstraZeneca, Sanofi, Novo Nordisk
Country Covered: India
Study Period: 2019 - 2030
Major Players: Eli Lilly and Company, Boehringer Ingelheim, AstraZeneca, Sanofi, Novo Nordisk
Country Covered: Australia
Study Period: 2019 - 2030
Major Players: Eli Lilly and Company, Boehringer Ingelheim, AstraZeneca, Sanofi, Novo Nordisk
Country Covered: New Zealand
Study Period: 2019 - 2030
Major Players: Sanofi, Eli Lilly and Company, Novo Nordisk, Boehringer Ingelheim, AstraZeneca
Country Covered: India
Study Period: 2019 - 2030
Major Players: Sanofi, Eli Lilly and Company, Astellas Pharma, Janssen, AstraZeneca
Country Covered: Malaysia
Study Period: 2019 - 2030
Major Players: AstraZeneca, Astellas Pharma, Janssen, Eli Lilly and Company, Sanofi
Region Covered: Asia
Study Period: 2021 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbvie, Bristol-Myers Squibb, Roche, Gilead Sciences, Merck
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: 3M, ACell, BSN Medical, Cardinal Health, Convatec
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: 3M, Beckton Dickinson, bioMérieux, Sterigenics International, Johnson & Johnson
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: 3M, Blistex, Colgate-Palmolive Company, Church & Dwight, GlaxoSmithKline
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Smiths Group, Johnson & Johnson, Molnlycke Health Care, 3M, Cardinal Health
Region Covered: Asia
Study Period: 2021 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: DJO Global, Teikoku Pharma, Zimmer Biomet, 3M, AKSIGEN
Region Covered: Asia
Study Period: 2021 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Koninklijke Philips, Colgate-Palmolive Company, DMG Dental, VOCO, Dentsply Sirona
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Alcon, Bausch Health, Johnson & Johnson, Carl Zeiss, Topcon
Region Covered: Asia
Study Period: 2024 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Johnson & Johnson, Sanofi, GlaxoSmithKline, Roche, Leti Pharma
Filter Reports
By Countries
